Constitutive COX-2 activity in cardiomyocytes confers permanent cardioprotection Constitutive COX-2 expression and cardioprotection. (Q44374395)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19084534%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

title

Constitutive COX-2 activity in cardiomyocytes confers permanent cardioprotection Constitutive COX-2 expression and cardioprotection (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19084534%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19084534%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Ignasi Barba

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19084534%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Lisardo Bosca

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19084534%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

Javier Inserte

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19084534%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Belén Molla

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19084534%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Paloma Martín-Sanz

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19084534%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Marta Casado

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19084534%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

David Garcia-Dorado

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19084534%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Paqui G Través

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19084534%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

publication date

25 November 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19084534%20AND%20SRC:MED&resulttype=core&format=json

Journal of Molecular and Cellular Cardiology

18 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19084534%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

46

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19084534%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19084534%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

160-168

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19084534%20AND%20SRC:MED&resulttype=core&format=json

Prostaglandin endoperoxide synthase: regulation of enzyme expression

18 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.011

Selective COX-2 inhibition improves endothelial function in coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.011

COX-2 in play at the AHA and the FDA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.011

Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.011

COX-2 suppresses tissue factor expression via endocannabinoid-directed PPARdelta activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.011

Regulation of thrombomodulin expression in human vascular smooth muscle cells by COX-2-derived prostaglandins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.011

Induction of cyclooxygenase-2 and activation of nuclear factor-kappaB in myocardium of patients with congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.011

Inhibition of COX pathway in experimental myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.011

Cyclooxygenase-2 inhibition increases mortality, enhances left ventricular remodeling, and impairs systolic function after myocardial infarction in the pig.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.011

Cyclooxygenase-1 and -2 knockout mice demonstrate increased cardiac ischemia/reperfusion injury but are protected by acute preconditioning.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.011

Discovery of a new function of cyclooxygenase (COX)-2: COX-2 is a cardioprotective protein that alleviates ischemia/reperfusion injury and mediates the late phase of preconditioning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.011

Prostaglandins mediate the cardioprotective effects of atorvastatin against ischemia-reperfusion injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.011

Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.011

Cardiospecific overexpression of the prostaglandin EP3 receptor attenuates ischemia-induced myocardial injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.011

Prostaglandin E2 protects the heart from ischemia-reperfusion injury via its receptor subtype EP4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.011

Reduction of infarct size by selective stimulation of prostaglandin EP(3)receptors in the reperfused ischemic pig heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.011

Selective activation of E-type prostanoid(3)-receptors reduces myocardial infarct size. A novel insight into the cardioprotective effects of prostaglandins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.011

Roles of prostaglandin I(2) and thromboxane A(2) in cardiac ischemia-reperfusion injury: a study using mice lacking their respective receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.011

Arachidonic acid causes cell death through the mitochondrial permeability transition. Implications for tumor necrosis factor-alpha aopototic signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.011

Interaction of free fatty acids with mitochondria: coupling, uncoupling and permeability transition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.011

Arachidonic acid interaction with the mitochondrial electron transport chain promotes reactive oxygen species generation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.011

Cyclooxygenase inhibition aggravates ischemia-reperfusion injury in the perfused guinea pig heart: involvement of isoprostanes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.011

Cytochrome P450: major player in reperfusion injury.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.011

Protection against Fas-induced liver apoptosis in transgenic mice expressing cyclooxygenase 2 in hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.011

Induction of cyclo-oxygenase 2 in brains of patients with Down's syndrome and dementia of Alzheimer type: specific localization in affected neurones and axons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.011

Ozone-induced production of nitric oxide and TNF-alpha and tissue injury are dependent on NF-kappaB p50.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.011

Cellular localization of cyclooxygenase-1 and cyclooxygenase-2 in the normal mouse, rat, and human retina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.011

Effects of marine 2-polyprenyl-1,4-hydroquinones on phospholipase A2 activity and some inflammatory responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.011

Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.011

Calpain-mediated impairment of Na+/K+-ATPase activity during early reperfusion contributes to cell death after myocardial ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.011

1H NMR-based metabolomic identification of at-risk areas after myocardial infarction in swine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.011

FATTY ACID COMPONENTS OF RAT-TISSUE LIPIDS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.011

Inducible nitric oxide synthase modulates cyclooxygenase-2 activity in the heart of conscious rabbits during the late phase of ischemic preconditioning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.011

Cardioprotection afforded by inducible nitric oxide synthase gene therapy is mediated by cyclooxygenase-2 via a nuclear factor-kappaB dependent pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.011

Trophic effects of the cyclooxygenase-2 product prostaglandin E(2) in cardiac myocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.011

Prostaglandin E(2) receptors, EP2 and EP4, differentially modulate TNF-alpha and IL-6 production induced by lipopolysaccharide in mouse peritoneal neutrophils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.011

Prostanoid receptors: structures, properties, and functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.011

Selective activation of the prostanoid EP(3) receptor reduces myocardial infarct size in rodents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.011

EP(4) prostanoid receptor coupling to a pertussis toxin-sensitive inhibitory G protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.011

Peptide leukotriene receptor antagonism in myocardial ischaemia and reperfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.011

12-Lipoxygenase-derived eicosanoids protect against myocardial ischemia/reperfusion injury via activation of neuronal TRPV1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.011

12-lipoxygenase in opioid-induced delayed cardioprotection: gene array, mass spectrometric, and pharmacological analyses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.011

Mechanisms by which epoxyeicosatrienoic acids (EETs) elicit cardioprotection in rat hearts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.11.011